| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;93:519-524.)
© 1996 American Heart Association, Inc.
Articles |
Exploration of the Precision of Classifying Sudden Cardiac Death
Implications for the Interpretation of Clinical Trials
From the Sections of Cardiology, Departments of Medicine, Baylor College of Medicine, Houston, Tex (C.M.P.); Yale University School of Medicine, New Haven, Conn (M.H.S.); Columbia University College of Physicians and Surgeons, New York, NY (J.A.R.); and Telectronics, Inc, Englewood, Colo (P.S.G., M.L.H.).
Correspondence to Craig M. Pratt, MD, Professor of Medicine, Baylor College of Medicine, 6535 Fannin, MS F1001, Houston, TX 77030.
Background As cardiovascular clinical trials improve in sophistication and therapies target specific cardiac mechanisms of death, a more objective and precise system to identify specific cause of death is needed. Ideally, sudden cardiac death would describe patients dying of ventricular tachycardia and ventricular fibrillation. In this context, we explored the precision of current sudden death classification and implications for clinical trials.
Methods and Results Deaths were analyzed in 834 patients who received an automatic implantable cardioverter-defibrillator (ICD). Three arrhythmia experts used a standard prospective classification system to classify deaths into accepted categories: sudden cardiac, nonsudden cardiac, and noncardiac. New aspects to this study included analysis of autopsy results and ICD interrogation for arrhythmias at the time of death. All of the patients receiving the ICD previously had documented sustained ventricular tachycardia/fibrillation or cardiac arrest. Of the 109 subsequent deaths in the 834-patient database, 17 (16%) were classified as sudden cardiac. Compared with the nonsudden cardiac and noncardiac categories, sudden cardiac death was more often identified in outpatients (59% versus 10%) and witnessed less often (41% versus 86%; both P<.001). The autopsy information contradicted and changed the clinical perception of a "sudden cardiac death" in 7 cases (myocardial infarction [n=1], pulmonary embolism [n=2], cerebral infarction [n=1], ruptured thoracic [n=1], and abdominal aortic aneurysms [n=2]). Interpretable ICD interrogation was available in 53% of the deaths (47% unavailable: buried, programmed off, or other technical reasons). When evaluated, only 7 of 17 "sudden deaths" were associated with ICD discharges near the time of death.
Conclusions Even in a group of patients with an ICD, deaths classified as sudden cardiac frequently were not associated with ventricular tachycardia or ventricular fibrillation and were often noncardiac. It is possible to create a wide range of sudden cardiac death rates (more than fourfold) using the identical clinical database despite objective, prespecified criteria. Autopsy results frequently reveal noncardiac causes of clinical events simulating sudden cardiac death. ICD interrogation revealed that ICD discharges were often related to terminal arrhythmias incidental to the primary pathophysiological process leading to death.
Key Words: death, sudden • trials • implantable cardioverter-defibrillator
This article has been cited by other articles:
 |
|
 |
|
  J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation, September 30, 2008; 118(14): 1497 - 1518. [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Groh, M. R. Groh, C. Saha, J. C. Kincaid, Z. Simmons, E. Ciafaloni, R. Pourmand, R. F. Otten, D. Bhakta, G. V. Nair, et al. Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1 N. Engl. J. Med., June 19, 2008; 358(25): 2688 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A Brady and G Lin The authors' reply Heart, June 1, 2008; 94(6): 793 - 793. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Patel and J. T. Heywood Mode of Death in Patients With Systolic Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 127 - 136. [Abstract] [PDF]
|
|
|
|
|
|
M. H. Schoenfeld Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist Circulation, February 6, 2007; 115(5): 638 - 653. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator? Chest, October 1, 2005; 128(4): 2626 - 2632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Circulation, May 17, 2005; 111(19): 2537 - 2549. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Thygesen and B. F Uretsky Acute ischaemia as a trigger of sudden cardiac death Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D88 - D90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Bigi, L Cortigiani, P Colombo, A Desideri, J J Bax, and O Parodi Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions Heart, September 1, 2003; 89(9): 1009 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Huikuri, J. M. Tapanainen, K. Lindgren, P. Raatikainen, T. H. Makikallio, K. E. Juhani Airaksinen, and R. J. Myerburg Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era J. Am. Coll. Cardiol., August 20, 2003; 42(4): 652 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Moss Dead is dead, but can we identify patients at increased risk for sudden cardiac death? J. Am. Coll. Cardiol., August 20, 2003; 42(4): 659 - 660. [Full Text] [PDF]
|
|
|
|
|
|
H. V. Huikuri, T. H. Makikallio, M. J. P. Raatikainen, J. Perkiomaki, A. Castellanos, and R. J. Myerburg Prediction of Sudden Cardiac Death: Appraisal of the Studies and Methods Assessing the Risk of Sudden Arrhythmic Death Circulation, July 8, 2003; 108(1): 110 - 115. [Full Text] [PDF]
|
|
|
|
|
|
J.u. Schlapfer, F. Rapp, L. Kappenberger, and M. Fromer Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: Results of long-term follow-up J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1813 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Angelini, Z.-J. Zheng, J. B. Croft, W. H. Giles, and G. A. Mensah Sudden Cardiac Death: Do We Know What We Are Talking About? * Response Circulation, May 28, 2002; 105 (21): e182 - e182. [Full Text] [PDF]
|
|
|
|
|
|
R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, B. Stanek, and R. Pacher B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure Circulation, May 21, 2002; 105(20): 2392 - 2397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Mitchell, E. A. Pineda, J. L. Titus, P. M. Bartosch, and D. G. Benditt Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bailey, A. S. Berson, H. Handelsman, and M. Hodges Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1902 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. V. Huikuri, A. Castellanos, and R. J. Myerburg Sudden Death Due to Cardiac Arrhythmias N. Engl. J. Med., November 15, 2001; 345(20): 1473 - 1482. [Full Text] [PDF]
|
|
|
|
 |
|
 S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]
|
|
|
|
 |
|
 F. Lombardi, T. H Makikallio, R. J Myerburg, and H. V Huikuri Sudden cardiac death: role of heart rate variability to identify patients at risk Cardiovasc Res, May 1, 2001; 50(2): 210 - 217. [Full Text] [PDF]
|
|
|
|
|
|
G. Gronefeld and S. H Hohnloser What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death? Cardiovasc Res, May 1, 2001; 50(2): 232 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Raitt, E. G. Renfroe, A. E. Epstein, J. H. McAnulty, P. Mounsey, J. S. Steinberg, S. E. Lancaster, R. L. Jadonath, and A. P. Hallstrom "Stable" Ventricular Tachycardia Is Not a Benign Rhythm : Insights From the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry Circulation, January 16, 2001; 103(2): 244 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Reiffel The Importance of Considering Trial Design When Interpreting Clinical Trial Results Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(1): 17 - 25. [Abstract] [PDF]
|
|
|
|
|
|
H. V. Huikuri, T. Makikallio, K. E. J. Airaksinen, R. Mitrani, A. Castellanos, and R. J. Myerburg Measurement of heart rate variability: a clinical tool or a research toy? J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1878 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.M Pratt, A.J Camm, J.T Bigger Jr, G Breithardt, R.W.F Campbell, A.E Epstein, L.J Kappenberger, K.-H Kuck, S Pocock, S Saksena, et al. Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems? Eur. Heart J., November 1, 1999; 20(21): 1538 - 1552. [Abstract] [PDF]
|
|
|
|
|
|
The AVID Investigators Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1552 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brooksby, P.D. Batin, J. Nolan, S.J. Lindsay, R. Andrews, M. Mullen, W. Baig, A.D. Flapan, R.J. Prescott, J.M.M. Neilson, et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART) Eur. Heart J., September 2, 1999; 20(18): 1335 - 1341. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Lauer, E. H. Blackstone, J. B. Young, and E. J. Topol Cause of death in clinical research: Time for a reassessment? J. Am. Coll. Cardiol., September 1, 1999; 34(3): 618 - 620. [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Goldberger Treatment and Prevention of Sudden Cardiac Death: Effect of Recent Clinical Trials Arch Intern Med, June 28, 1999; 159(12): 1281 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Bigger Jr, W. Whang, J. N. Rottman, R. E. Kleiger, C. D. Gottlieb, P. B. Namerow, R. C. Steinman, and N. A. M. Estes III Mechanisms of Death in the CABG Patch Trial : A Randomized Trial of Implantable Cardiac Defibrillator Prophylaxis in Patients at High Risk of Death After Coronary Artery Bypass Graft Surgery Circulation, March 23, 1999; 99(11): 1416 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Pires, M. H. Lehmann, R. T. Steinman, J. J. Baga, C. D. Schuger, and Participating Investigators Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses J. Am. Coll. Cardiol., January 1, 1999; 33(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Cheema, K. Sheu, M. Parker, A. H. Kadish, and J. J. Goldberger Nonsustained Ventricular Tachycardia in the Setting of Acute Myocardial Infarction : Tachycardia Characteristics and Their Prognostic Implications Circulation, November 10, 1998; 98(19): 2030 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hall, S.-I. Ando, J. S. Floras, and T. D. Bradley Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure J Appl Physiol, October 1, 1998; 85(4): 1476 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. O'Connor, J. D. Birkmeyer, L. J. Dacey, H. B. Quinton, C. A.S. Marrin, N. J.O. Birkmeyer, J. R. Morton, B. J. Leavitt, C. T. Maloney, F. Hernandez, et al. Results of a regional study of modes of death associated with coronary artery bypass grafting Ann. Thorac. Surg., October 1, 1998; 66(4): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study Circulation, August 18, 1998; 98(7): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Block, E. C. Peterson, R. Krone, K. Kesler, E. Hannan, G. T. O'Connor, and K. Detre Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection J. Am. Coll. Cardiol., July 1, 1998; 32(1): 275 - 282. [Abstract] [Full Text] [PDF]
|
|